SCA
MDCO

Secor Capital Advisors’s Medicines Co MDCO Stock Holding History

Secor Capital Advisors’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-8,381
Closed -$232K – 584
2014
Q4 		$232K Sell
8,381
-4,372
-34% -$108K 0.1% 318
2014
Q3 		$285K Buy
+12,753
New +$324K 0.16% 224

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Secor Capital Advisors's MDCO Position: Q1 2015 in Review

Secor Capital Advisors sold out of Medicines Co (MDCO) in Q1 2015, closing a stake of 8,381 shares — an estimated $232K sold.

Secor Capital Advisors first reported a position in MDCO in Q3 2014 and held it in 2 quarters. The position peaked at $285K in Q3 2014. 184 funds tracked by Wall St. Rank hold MDCO as of Q1 2015.

  • Secor Capital Advisors reported no remaining Medicines Co position as of Q1 2015 after selling out during the quarter.
  • Secor Capital Advisors sold 8,381 Medicines Co shares in Q1 2015, an estimated $232K.
  • Secor Capital Advisors first reported a position in Medicines Co in Q3 2014 and held it in 2 quarters.
  • Secor Capital Advisors's Medicines Co position peaked at $285K in Q3 2014.
  • 184 funds tracked by Wall St. Rank held Medicines Co as of Q1 2015.

Based on Secor Capital Advisors's 13F filing for Q1 2015, filed 12 May 2015.